Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung
Clinical trial NCT02713828 · TERMINATED
Trial details
- NCT number
- NCT02713828
- Sponsor
- PrECOG, LLC.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-10
- Primary completion
- 2018-05-29
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.